treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk.
.
glenmark pharma launches generic version of asthma drug in denmark
.
advertisement
.imagine a congressional hearing held before media cameras, with reporters all over the us and europe ready with shocking articles about one of the leading causes of death�
.
kpcc in person
.
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).
.
the longest one patient waited for treatment following a gp referral in 2017 was 541 days - against a target of 62 days.
.